Table 1 Demographic of patient for IHC TWEAK and Fn14 in synovial tissues
| Â | Control | Active RA | Inactive RA | OA |
|---|---|---|---|---|
Gender (Female/Male) | 4/6 | 6/4 | 3/6 | 3/7 |
Mean Age (years) (range) | 40.2 (25 to 58) | 69.2 (31 to 86) | 72.33 (60 to 79) | 69.3 (55 to 77) |
Disease duration (months) (range) | NA | 3.1 (2 to 6) | 21.77 (7 to 36) | NA |
Rheumatoid Factor | NA | 6/10 | 5/9 | NA |
Erosions | NA | 2/10 | 2/9 | NA |
C-Reactive protein median (mg/ml) (range) | NA | 67.5 (27.0 to 307.0) | 6 (2.0 to 26.0) | NA |
Treatment | NA | 9 NSAIDs | 5 im gold | 6 NSAIDs |
| Â | Â | 1 prednisolone | 2 methotrexate | 3 NSAIDs |
| Â | Â | Â | 1sulphasalazine | 1 panadeine |
| Â | Â | Â | 1 plaquenil | Â |